Pathology

John D. Kemp, MD

Portrait

Associate Chair for Quality, Safety, and Performance Improvement
Associate Director of Immunopathology Laboratory
Medical Consultant, Serology Laboratory, Veterans Affairs Medical Center
Professor of Pathology  - Anatomic Pathology

Contact Information

Primary Office: C612 General Hospital
Iowa City, IA 52242
Primary Office Phone: 319-384-9611

Office: C612 General Hospital
Iowa City, IA 52242

Email: john-kemp@uiowa.edu

Education

BA, Political Science, Indiana University
MD, Indiana University School of Medicine

Intern, Pathology, Yale-New Haven Hospital
Residency, Anatomic Pathology, Yale-New Haven Hospital
Fellowship, Immunology, Yale University, Department of Pathology
Residency, Laboratory Medicine, Yale-New Haven Hospital

Licensure and Certifications

Clinical Pathology, The American Board of Pathology
Anatomic Pathology, The American Board of Pathology

Education/Training Program Affiliations

Interdisciplinary Graduate Program in Informatics

Research Summary

Administration: As the Associate Chair for Quality, Safety, and Performance Improvement, my goal is to facilitate innovation in Pathology as well as collaboration with other University of Iowa Healthcare providers as we all seek to provide high quality medical care in a safe, efficient, and cost effective manner.

Education/Research: Pathology Departments can and should play a much more significant role in the education of future biomedical scientists. In support of that goal, I created a new model course for teaching the pathogenesis of major human diseases to 1st and 2nd year graduate students in the biomedical sciences.

Service/Research: Principal interests are basic Immunology and diagnostic Immunopathology. Prior research has involved autoimmunity, immunoregulation, immunodeficiency, immunotherapy, and the study of the structure of the human transferrin receptor gene.

All Publications

Hardy R, Carmack C, Shinton S, Kemp J, Hayakawa K.  Pillars article: resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.  Journal of immunology (Baltimore, Md. : 1950).  2012 October. 189(7):3271-83.
[PubMed]

Kemp J.  Enhancing Transfusion Safety with an Innovative Bar-Code-Based Tracking System.  Am J Med Quality.  2009. 24(2(Suppl)):31S-32S.

Askeland R, McGrane S, Reifert D, Kemp J.  Enhancing transfusion safety with an innovative bar-code-based tracking system.  Healthcare quarterly (Toronto, Ont.).  2009. 12 Spec Issue:85-9.
[PubMed]

Askeland R, McGrane S, Levitt J, Dane S, Greene D, Vandeberg J, Walker K, Porcella A, Herwaldt L, Carmen L, Kemp J.  Improving transfusion safety: implementation of a comprehensive computerized bar code-based tracking system for detecting and preventing errors.  Transfusion.  2008 July. 48(7):1308-17.
[PubMed]

Dee F, Haugen T, Wynn P, Leaven T, Kemp J, Cohen M.  A Web-based database for pathology faculty effort reporting.  Human pathology.  2008 April. 39(4):489-97.
[PubMed]

Bell A, Kemp J, Raife T.  A comparative labor productivity analysis of blood collection centers.  Transfusion.  2008 February. 48(2):258-63.
[PubMed]

Reifert D, Greene D, Hillberry C, Askeland R, Kemp J.  Further Data Driven Indications of Enhanced patient Safety with a Barcode-based Computerized Tracking System.  2008. 

Weydert J, Nobbs N, Feld R, Kemp J.  A simple, focused, computerized query to detect overutilization of laboratory tests.  Archives of pathology & laboratory medicine.  2005 September. 129(9):1141-3.
[PubMed]

Levitt J, Dane S, Greene D, VandeBerg J, Kemp J.  Implementation of a bar code based computerized tracking system for patient identification and blood product administration in the transfusion process.  2005. 

Kemp J, Bowser R.  PhD graduate training programs in pathology: 2003 report from the American Society for Investigative Pathology workshop on pathology graduate education.  Human pathology.  2004 July. 35(7):785-9.
[PubMed]

Weydert J, Nobbs N, Feld R, Kemp J.  A simple, focused, computerized query to detect overutilization of laboratory tests.  2004. 

Olakanmi O, Rasmussen G, Lewis T, Stokes J, Kemp J, Britigan B.  Multivalent metal-induced iron acquisition from transferrin and lactoferrin by myeloid cells.  Journal of immunology (Baltimore, Md. : 1950).  2002 August. 169(4):2076-84.
[PubMed]

Rubin B, Pfaller M, Kemp J.  Strategies to Affect Laboratory Test Utilization in a Budget Constrained Environment.  Laboratory Medicine.  2002. 33(10).

Cerhan J, Wallace R, Dick F, Kemp J, Parker A, Zheng W, Sellers T, Folsom A.  Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  2001 April. 10(4):361-8.
[PubMed]

Kemp J.  Agammaglobulinemia.  2001. 

Biga R, Mahoney L, Krauss R, Kemp J, Stewart B, Lauer R, Burns T.  Association of iron, c-reactive protein, and low-density lipoprotein particle size with coronary artery calcification: Preliminary results from the Muscatine study.  2001. 

Goeken J, Kemp J.  Comparison of IFA and commercial ELISAs for ANCA testing: Optimal strategy for maximizing sensitivity and specificity for vasculitis.  2001. 

Kemp J.  Positive Antinuclear Antibody (ANA).  2001. 

Parker A, Cerhan J, Dick F, Kemp J, Habermann T, Wallace R, Sellers T, Folsom A.  Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women.  Leukemia & lymphoma.  2000 April. 37(4-Mar):341-9.
[PubMed]

Kovár J, Kemp J.  Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro.  In vitro cellular & developmental biology. Animal.  2000 March. 36(3):151-2.
[PubMed]

Olakanmi O, Rasmussen G, Lewis T, Kemp J, Britigan B.  A non-endocytotic Mechansim of Iron Acquisition from Transferrin and Lactoferrin by Human Myeloid Cells.  2000. 

Goeken J, Kemp J.  Comparison of ANCA testing by IFA with four commercial ELISAs: A strategy to maximize both sensitivity and specificity.  2000. 

Goeken J, Kemp J.  Comparison of ANCA Testing by IFA with four commercial ELISAs: A strategy to maximize both sensitivity and specificity.  2000. 

Goeken J, Kemp J.  Comparison of IFA and commercial ELISAs for ANCA testing: Optimal strategy to maximizing sensitivity and specificity for vasculitis.  2000. 

Goeken J, Kemp J, Perino-Philips M, Ippolito L, Mitroc F, Labrecque D.  Diagnostic utility of anti-neutrophil cytoplasmic antibody testing (ANCA) in chronic liver diseases.  2000. 

Goeken J, Kemp J, Perino-Philips M, Ippolito L, Mitroc F, Labrecque D.  Diagnostic utility of anti-neutrophil cytoplasmic antibody testing in chronic liver diseases.  2000. 

Goeken J, Kemp J, Perino-Philips M, Ippolito L, Mitros F, Labrecque D.  Diagnostic utility of anti-neutrophil cytoplasmic antibody testing in chronic liver diseases.  2000. 

Cerhan J, Wallace R, Dick F, Kemp J, Parker A, Lutz C, Zhen W, Folsom A, Sellers T.  Abs #1395Prior blood transfusion and risk of Non-Hodgkin’s Lymphoma (NHL) subtypes.  Proc Am Assoc Cancer Res.  1999 April. 40:210.

Kemp J.  A novel approach to teaching Laboratory Medicine to third and fourth year medical students.  1999 March. 

Goldman F, Ballas Z, Schutte B, Kemp J, Hollenback C, Noraz N, Taylor N.  Defective expression of p56lck in an infant with severe combined immunodeficiency.  The Journal of clinical investigation.  1998 July. 102(2):421-9.
[PubMed]

Kovar J, Valenta T, Spevakova K, Kemp J.  Apoptosis induced by iron deprivation in tumor cells.  1998 May. 

Kovar J, Valenta T, Spevakova K, Stunz L, Kriegerbeckova K, Kemp J.  Apoptosis induced by iron deprivation in cultured tumor cells.  1998. 

Evans P, Kemp J.  Exon/intron structure of the human transferrin receptor gene.  Gene.  1997 October. 199(2-Jan):123-31.
[PubMed]

Dreicer R, Kemp J, Stegink L, Cardillo T, Davis C, Forest P, See W.  A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer.  Cancer investigation.  1997. 15(4):311-7.
[PubMed]

Kemp J.  Analysis of the effects of iron deprivation on breast cancer cell lines in vitro and .  1997. 

Kovar J, Stunz L, Stewart B, Kriegerbeckova K, Ashman R, Kemp J.  Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13.  Pathobiology : journal of immunopathology, molecular and cellular biology.  1997. 65(2):61-8.
[PubMed]

Neumann R, Carrasquillo J, Weiner R, Falen S, Kemp J, Chen C.  Radionuclide Imaging.  New York: Oxford University Press.  1997. 

Kemp J.  Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor.  Histology and histopathology.  1997 January. 12(1):291-6.
[PubMed]

Kovar J, Stunz L, Stewart B, Kriegerbeckova K, Ashman R, Kemp J.  Abs # 2007 Direct evidence that iron deprivation alone is sufficient to induce apoptosis.  FASEB.  1996. V10#6:1460.

Best C, Medina K, Tygrett L, Kemp J, Kincade P, Waldschmidt T.  Abs #2651 The effects of anti-CD43 antibody treatment on in vitro lymphoid and myeloid maturation.  FASEB.  1996. V10#6:1460.

Evans P, Hagen M, Sightler H, Kemp J.  Abs #877 Determining the exon/intron structure of the human transferrin receptor gene.  FASEB.  1996. V10#6:A1151.

Kovar J, Stunz L, Stewart B, Kriegerbeckova K, Ashman R, Kemp J.  Apoptosis induced by iron deprivation.  1996. 

Kovar J, Kemp J, Stunz L, Stewart B, Kriegerbeckova K.  Apoptosis induced by iron deprivation in cultured tumor cells.  1996. 

Kovar J, Stunz L, Stewart B, Kriegerbeckova K, Ashman R, Kemp J.  Direct evidence that iron deprivation alone is sufficient to induce apoptosis.  1996. 

Newmann R, Kemp J, Weiner R.  Gallium-67 imaging for detection of malignant disease.  MD: Williams & Wilkins.  1996. 

Kemp J, Cardillo T, Stewart B, Kehrberg E, Weiner G, Hedlund B, Naumann P.  Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.  Cancer research.  1995 September. 55(17):3817-24.
[PubMed]

Kemp J, Cardillo T, Kerberg E, Weiner G, Naumann P.  Abs #1200 Iron deprivation treatment of murine lymphoma in vitro and in vivo: A comparison of protocols using either one or two IgG monoclonal anti-transferrin receptor antibodies with the hydroxyethyl starch - deferoxamine.  FASEB.  1995. V9#3:A206.

Kemp J, Cardillo T, Naumann P, Stewart B.  Abs #6057 The ability of anti-transferrin receptor antibodies to inhibit iron uptake in tumor cells appears to be related to the initial cell surface density of the receptor.  FASEB.  1995. V9#4:A1045.

Kovar J, Naumann P, Stewart B, Kemp J.  Differing sensitivity of non-hematopoietic human tumors to synergistic anti-transferrin receptor monoclonal antibodies and deferoxamine in vitro.  Pathobiology : journal of immunopathology, molecular and cellular biology.  1995. 63(2):65-70.
[PubMed]

Kovar J, Kemp J, Naumann P, Stewart B.  Inhibition of human tumors in vitro by synergistic anti-transferrin receptor monoclonal antibodies and deferoxamine.  FASEB.  1995. V9#4:A1045.

Best C, Kemp J, Waldschmidt T.  Murine B cell subsets defined by CD23.  Methods: A Companion to Methods in Enzymology.  1995. 8:3-10.

Best C, Medina L, Tygrett L, Kemp J, Kincade P, Waldschmidt T.  The effects of anti-CD43 antibody treatment on in vitro lymphoid and myeloid maturation.  1995. 

Raife T, Lager D, Kemp J, Dick F.  Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia.  American journal of clinical pathology.  1994 March. 101(3):296-9.
[PubMed]

Kemp J, Naumann P, Cardillo T, Kovar J.  Abs #2921 Inhibition of tumor growth in vitro and in vivo by combined treatment with deferoxamine and IgG mabs against the transferrin receptor.  FASEB.  1994. V8#4:A504.

Best C, Kemp J, Waldschmidt T.  Abs #4567 The distribution and characterization of murine CD43 isoforms.  FASEB.  1994. V9#5:A787.

Bonsib S, Goeken J, Kemp J, Chandran P, Shadur C, Wilson L.  Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease = report of six cases.  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.  1993 September. 6(5):526-30.
[PubMed]

Greer J, Koerner T, Hayakawa K, Hardy R, Kemp J.  The 3G11+ antigen, a marker for murine CD4+ TH1 lymphocytes, is a ganglioside.  Glycobiology.  1993 August. 3(4):391-401.
[PubMed]

Kemp J.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.  Journal of clinical immunology.  1993 March. 13(2):81-92.
[PubMed]

Best C, Kemp J, Tygrett L, Waldschmidt T.  CD43 (leukosalin) epitopes are differentially expressed on murine B cells.  1993. 

Hughes J, Kemp J.  CD43 expression in non-Hodgkin's lymphomas.  1993. 

Baecher-Allan C, Kemp J, Dorfman K, Barth R, Frelinger J.  Differential epitope expression of Ly-48 (mouse leukosialin).  Immunogenetics.  1993. 37(3):183-92.
[PubMed]

Teeranratkul P, Goeken J, Kemp J, Thorson J.  Identification of apparent dual ANCA specificities in a subset of patients with systemic vasculitis.  New York: Plenum Press.  1993. 

Teeraratkul P, Thorson J, Kemp J, Goeken J.  Identification of apparent dual ANCA specificities in a subset of patients with systemic vasculitis and crescentic glomerulonephritis.  Advances in experimental medicine and biology.  1993. 336:455-9.
[PubMed]

Kemp J, Naumann P, Cardillo T, Hare J, Tham C, Stewart B.  Inhibition of tumor growth in vitro and in vivo by combined treatment with deferoxamine and IgG Mabs against the transferrin receptor.  1993. 

Greer J, Koerner T, Hayakawa K, Hardy R, Kemp J.  The 3G11 antigen, a marker for murine TH1 lymphocytes, is a disialo-ganglioside other than GD1a.  1993. 

Cardillo T, Smith K, Stewart B, Naumann P, Kemp J.  The growth inhibitory effects of anti-transferrin receptor antibodies appear to be related to the initial cell surface density of transferrin receptors.  1993. 

Ashman R, Schaffer F, Kemp J, Yokoyama W, Zhu Z, Cooper M, Volanakis J.  Genetic and immunologic analysis of a family containing five patients with common-variable immune deficiency or selective IgA deficiency.  Journal of clinical immunology.  1992 November. 12(6):406-14.
[PubMed]

Kemp J, Thorson J, Stewart B, Naumann P.  Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.  Cancer research.  1992 August. 52(15):4144-8.
[PubMed]

Cardillo T, Naumann P, Stewart B, Kemp J.  Abs #2047 Inhibition of tumor growth by combined treatment with IgG Mabs against the transferrin receptor and deferoxamine: Evidence for a threshold model of iron deprivation toxicity in hematopoeitc tumors and detection of a resistant epithelial cell line.  AACR.  1992. 

Greer J, Koerner T, Hayakawa K, Hardy R, Kemp J.  Abs #2805 Characterization of a novel ganglioside expressed in a functional subset of murine CD4+ T cells.  FASEB.  1992. 

Teeraratkul P, Thorson J, Kemp J, Goeken J.  Abs #650 Comparison of IFA and capture EIA methods for detection of anti-myeloperoxidase antibodies in systemic vasculitis.  FASEB.  1992. 

Kemp J, Hare J, Naumann P, Stewart B.  Abs #6508 Inhibition of growth of murine and human tumors by combined treatment with IgG Mabs against the transferrin receptor and deferoxamine: Evidence for a critical threshold model of iron deprivation toxicity.  FASEB.  1992. 

Kemp J, Smith K, Mayer J, Gomez F, Thorson J, Naumann P.  Effects of anti-transferrin receptor antibodies on the growth of neoplastic cells.  Pathobiology: journal of immunopathology, molecular and cellular biology.  1992. 60(1):27-32.
[PubMed]

Raife T, Lager D, Dick F, Kemp J.  Expression of BA-1 (CD24) predicts monocytic lineage in acute myeloid leukemia.  1992. 

Teeraratkul P, Thorson J, Kemp J, Goeken J.  Identification of apparent dual ANCA specificities in a subset of patients with systemic vasculitis and crescentic glomerulonephritis.  1992. 

K Z, Kemp J.  Lack of correlation of Natural Killer (NK) cell numbers and function.  J All/Clin Immunol.  1992. 89:266.

Jensen C, Burgart L, Stewart B, Naumann P, Kemp J.  Melanotransferrin (p97) flow cytometric studies of expression and regulation in B lymphoblastoid cell lines and immunohistochemical studies of expression in brain vasculature.  1992. 

Laszewski M, Belding P, Feddersen R, Lutz C, Goeken J, Kemp J, Dick F.  Clonal immunoglobulin gene rearrangement in the infarcted lymph node syndrome.  American journal of clinical pathology.  1991 July. 96(1):116-20.
[PubMed]

Hardy R, Carmack C, Shinton S, Kemp J, Hayakawa K.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.  The Journal of experimental medicine.  1991 May. 173(5):1213-25.
[PubMed]

Thorson J, Smith K, Gomez F, Naumann P, Kemp J.  Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine.  Cellular immunology.  1991 April. 134(1):126-37.
[PubMed]

Ballas Z, Kemp J.  Abnormal CD4+ CD45RA+ subset distribution can be a transient phenomenon.  1991. 

Horning L, Hardarson S, Kemp J, Goeken J.  Automated immunohistochemistry: Evaluation of lymphoid lesions using frozen section.  1991. 

Greer J, Koerner T, Hayakawa K, Hardy R, Kemp J.  Functional subsets of murine CD4+ T cells are defined, in part, by expression of a novel ganglioside.  1991. 

Ashman R, Schaffer R, Kemp J, Yokoyama W, Cooper M, Volanakis J.  Genetic and immunologic analysis of a family containing 5 patients with common variable immune deficiency or selective IgA deficiency.  1991. 

Kemp J, Thorson J, Mayer J, Naumann P.  Inhibition of tumor growth by combination treatment with IgG Mabs against the transferrin receptor and deferoxamine: Evidence for a threshold model of iron deprivation toxicity.  1991. 

Ogata L, Naumann P, Kemp J.  Studies of murine B cell differentiation using Mabs against murine leukosialin/sialophorin (CD43).  1991. 

Kemp J.  The ferrobiology of neoplasia: Introduction, Part One.  Pathobiology.  1991. 59:1-2.

Kemp J.  The ferrobiology of neoplasia: Part Two.  Pathobiology.  1991. 60:1.

Goeken J, Bonsib S, Kemp J.  ANCA serology in rapidly progressive glomerulonephritis (RPGN) patients: patterns at a midwestern U.S. medical center.  1990 November 30. 

Vora A, Stunz L, Kemp J, Ashman R.  Two mechanisms of transferrin receptor induction by anti-Ig in B cells.  Journal of immunology (Baltimore, Md. : 1950).  1990 October. 145(7):2099-104.
[PubMed]

Laszewski M, Kemp J, Goeken J, Mitros F, Platz C, Dick F.  Clonal immunoglobulin gene rearrangement in nodular lymphoid hyperplasia of the gastrointestinal tract associated with common variable immunodeficiency.  American journal of clinical pathology.  1990 September. 94(3):338-43.
[PubMed]

Kemp J, Smith K, Kanner L, Gomez F, Thorson J, Naumann P.  Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.  Blood.  1990 September. 76(5):991-5.
[PubMed]

Laszewski M, Kamat D, Kemp J, Goeken J, Mitros F, Platz C, Dick F.  Immunophenotypic and genotypic characterization of primary non-Hodgkin's lymphoma of the gastrointestinal tract.  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.  1990 July. 3(4):423-8.
[PubMed]

Sandor M, Gajewski T, Thorson J, Kemp J, Fitch F, Lynch R.  CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin 4-producing T helper cell type 2 subset.  The Journal of experimental medicine.  1990 June. 171(6):2171-6.
[PubMed]

Kemp J, Smith K, Kanner L, Thorson J, Naumann P.  Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an IgG monoclonal antibody against the transferrin receptor.  1990 June. 

Lutz C, Galles M, Kemp J, Goeken J, Dick F.  Kappa immunoglobulin light chain gene rearrangement in a T-lineage chronic lymphocytic leukemia.  American journal of clinical pathology.  1990 May. 93(5):702-5.
[PubMed]

Kamat D, Laszewski M, Kemp J, Goeken J, Lutz C, Platz C, Dick F.  The diagnostic utility of immunophenotyping and immunogenotyping in the pathologic evaluation of lymphoid proliferations.  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.  1990 March. 3(2):105-12.
[PubMed]

Ballas Z, Turner J, Turner D, Goetzman E, Kemp J.  A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset.  The Journal of allergy and clinical immunology.  1990 February. 85(2):453-9.
[PubMed]

Bonsib S, Goeken J, Kemp J.  Co-expression of anti-neutrophil cytoplasmic antibody (ANCA) in anti-glomerular basement membrane mediated diseases.  1990. 

Goeken J, Bonsib S, Kemp J.  Co-expression of anti-neutrophil cytoplasmic antibody (ANCA) in Goodpasture's syndrome and AGBM nephritis.  1990. 

Ogata L, Naumann P, Kemp J.  Continuing studies of late stage B cell differentiation with a Mab that may recognize murine leukosialin/sialophorin.  1990. 

Kemp J, al. e.  Synergistic inhibition of lymphoid tumor growth in vitro by combined treatement with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.  1990. 

Sandor M, Kemp J.  T cell receptor driven regulation of Fc receptors on different subpopulations of murine T cells.  1990. 

Kemp J, Thorson J, Gomez F, Smith K, Cowdery J, Ballas Z.  Inhibition of lymphocyte activation with anti-transferrin receptor Mabs: a comparison of three reagents and further studies of their range of effects and mechanism of action.  Cellular immunology.  1989 August. 122(1):218-30.
[PubMed]

Futran J, Kemp J, Field E, Vora A, Ashman R.  Transferrin receptor synthesis is an early event in B cell activation.  Journal of immunology (Baltimore, Md. : 1950).  1989 August. 143(3):787-92.
[PubMed]

Wells K, Folberg R, Goeken J, Kemp J.  Temporal artery biopsies - Correlation of light microscopy and immunofluorescence microscopy.  Ophthalmology.  1989 July. 96(7):1058-64.
[PubMed]

Ogata L, Thorson J, Naumann P, Kemp J.  Abs # 6517 Further studies of an antigen expressed on terminally differentiating murine B cells.  FASEB.  1989. V3N4:A1348.

Hardy R, Kemp J, Hayakawa K.  Analysis of lymphoid population in SCID mice; detection of a potential B lymphocyte progenitor population present at normal levels in scid mice by three color flow cytometry with B220 and S7.  Current topics in microbiology and immunology.  1989. 152:19-25.
[PubMed]

Kemp J.  Analysis of lymphoid populations in SCID mice; detection of a potential B lymphocyte progenitor population present at normal levels in SCID mice by 3 color flow cytometry with B22O and S7.  1989. 

Greer J, Koerner T, Hayakawa K, Hardy R, Kemp J.  CD4+ T cell subsets are defined, in part, by differential expression of a ganglioside.  1989. 

Goeken J, Kemp J, Bonsib S.  Clinical and pathological implications of wider utilization of two distinct assays for ANCA.  1989. 

Sandor M, Thorson J, Kemp J, Lynch R.  Differential expression of Fc receptors on cloned TH1 and TH2 cells.  1989. 

Baecher C, Semcheski K, Pallant A, Kemp J, Frelinger J.  Expression of mouse leukosialin, a hematopoietic lineage marker.  1989. 

Thorson J, Gomez F, Naumann P, Smith K, Kemp J.  Selective inhibiton of TH1 but not TH2 clones by an anti-transferrin receptor antibody.  FASEB.  1989. V3N3:A814.

Flickinger F, Yuh W, Nichols R, Kemp J.  Solitary prostatic metastasis to the cerebellopontine angle: MR and CT findings.  Journal of computer assisted tomography.  1989. 13(6):1088-90.
[PubMed]

Vora A, Kemp J, Field E, Ashman R.  The mechanism of transferrin receptor induction by anti-Ig is altered by B cell Fc gamma receptor engagement.  1989. 

Radford J, Burns C, Jones M, Gingrich R, Kemp J, Edwards R, McFadden D, Dick F, Wen B.  Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  1989 January. 7(1):58-66.
[PubMed]

Davey D, Kamat D, Laszewski M, Goeken J, Kemp J, Trigg M, Purtilo D, Davis J, Dick F.  Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis.  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.  1989 January. 2(1):27-34.
[PubMed]

Lager D, Goeken J, Kemp J, Robinson R.  Squamous metaplasia of the prostate - An immunohistochemical study.  American journal of clinical pathology.  1988 November. 90(5):597-601.
[PubMed]

Gulley M, Ogata L, Thorson J, Dailey M, Kemp J.  Identification of a murine pan-T cell antigen which is also expressed during the terminal phases of B cell differentiation.  Journal of immunology (Baltimore, Md. : 1950).  1988 June. 140(11):3751-7.
[PubMed]

Argenyi Z, Van Rybroek J, Kemp J, Soper R.  Congenital angiomatoid malignant fibrous histiocytoma. A light-microscopic, immunopathologic, and electron-microscopic study.  The American Journal of dermatopathology.  1988 February. 10(1):59-67.
[PubMed]

Grimmer D, Landas S, Kemp J.  IgM antitrophoblast antibodies in a patient with a pregnancy-associated lupuslike disorder, vasculitis, and recurrent intrauterine fetal demise.  Archives of pathology & laboratory medicine.  1988 February. 112(2):191-3.
[PubMed]

Thorson J, Gomez F, Smith K, Naumann P, Kemp J.  Abs #5486 An IgG monoclonal antibody to the mouse transferrin receptor selectively inhibits T lymphocyte activation.  FASEB.  1988. V2N5:A1241.

Kamat D, Laszewski M, Goeken J, Kemp J, Dick F.  Abs #621 Analysis of lymphoid proliferations by immunopathologic and antigen receptor gene rearrangement studies.  FASEB.  1988. 2N4:A1241.

Argenyi Z, Wick M, Kemp J, Baldwin M.  Comparative immunohistochemical evaluation of benign and malignant spindle cell melanocytic lesions.  J Cutan Pathol.  1988. 15(5):294.

Ogata L, Gulley M, Thorson J, Naumann P, Kemp J.  Definition of a late-stage B cell differentiation antigen by a new rat monoclonal antibody.  1988. 

Ogata L, Thorson J, Naumann P, Kemp J.  Definition of a new late stage B cell differentiation antigen which may indicate commitment to terminal differentiation.  1988. 

Kemp J, Weinfeld H, Koerner T.  Effects on MHC-linked genes on hepatic ganglioside composition.  1988. 79:231-234.

Rohrer J, Kemp J.  Function and regulation of SRBC-induced contrasuppressor T cells which modulate suppression of MOPC-315 cell secretory differentiation in vivo and in vitro.  Immunologic research.  1988. 7(1):45-55.
[PubMed]

Laszewski M, Kamat D, Kemp J, Goeken J, Dick F.  Immunophenotypic and genotypic characterization of primary gastrointestinal lymphomas and lymphoid hyperplasias.  1988. 

Cowdery J, Kemp J, Ballas Z, Weber S.  Interleukin 1 induces T cell mediated differentiation of murine Peyer's patch B cells to IgA secretion.  Regional immunology.  1988. 1(1):9-14.
[PubMed]

Cowdery J, Kemp J, Ballas Z, Weber S.  Interleukin-1 induced T cell mediated augmentation of IgA secretion in cultured murine Peyer's Patch cells.  Elsevier.  1988. 

Koerner T, Kragt J, Walker K, Kemp J.  MHC-linked expression of murine hepatic gangliosides: Mode of inheritance and apparent effects of sex and substrain variation.  1988. 

Kemp J, Naumann P, Thorson J.  Modulation of lymphocyte activation by three rat monoclonal antibodies against the transferrin receptor.  1988. 

Kemp J, Turner J, Ballas Z.  Recurrent warts and epithelial malignancy in a patient with functional NK deficiency and an expanded CD3+CD4-CD8- population.  1988. 

Kemp J.  Specificity of trophoblast-reactive antibodies in human pregnancy.  Archives Pathology Laboratory Mediicine.  1988. 112(11):1081-2.

Futran J, Kemp J, Ashman R.  Transferrin receptor expression in B cell activation.  FASEB.  1988. 2N5:A1468.

Vora A, Kemp J, Ashman R.  Whole anti-Ig increases transferrin receptor expression on B lymphocytes while blocking proliferation.  1988. 

Radford J, Burns C, Gingrich R, Edwards R, McFadden D, Dick F, Kemp J.  Adult acute lymophoblastic leukemia (ALL): Update of HOP-L treatment program.  1987 May. 

Hart M, Waldschmidt M, Hanley-Hyde J, Moore S, Kemp J, Schelper R.  Brain microvascular smooth muscle expresses class II antigens.  Journal of immunology (Baltimore, Md. : 1950).  1987 May. 138(9):2960-3.
[PubMed]

Kemp J, Koerner T.  Further studies of H-2 linked effects on hepatic ganglioside composition.  Presented at the UCLA Symposium on Altered Glycosylation in Tumor Cells.  1987 April. 

Kemp J, Thorson J, McAlmont T, Horowitz M, Cowdery J, Ballas Z.  Role of the transferrin receptor in lymphocyte growth: a rat IgG monoclonal antibody against the murine transferrin receptor produces highly selective inhibition of T and B cell activation protocols.  Journal of immunology (Baltimore, Md. : 1950).  1987 April. 138(8):2422-6.
[PubMed]

Kemp J, Weinfeld H, Koerner T.  A quantitative analysis of H-2 linked effects on hepatic ganglioside composition.  Immunogenetics.  1987. 26(3):130-7.
[PubMed]

Laszewski M, Kamat D, Kemp J, Goeken J, Dick F.  Contribution of antigen receptor gene rearrangement studies to the immunopathologic analysis of lymphoid proliferations.  1987. 

Cowdery J, Kemp J, Ballas Z.  Interleukin-1 selectively induces IgA secretion in cultured murine Peyer's Patch cells.  1987. 

Lager D, Kemp J, Robinson R.  Prostatic squamous metaplasia: Immunohistochemical characterization with antibodies to Prostate Specific Antigen and Prostatic Acid Phosphatase.  1987. 

Carroll T, Schelper R, Goeken J, Kemp J.  Naming "malignant angioendotheliomatosis".  The New England journal of medicine.  1986 October. 315(14):895-6.
[PubMed]

Rohrer J, Kemp J.  Immunoglobulin-dependent helper T cells: studies in the MOPC-315 system suggest a novel surface antigen phenotype.  Journal of immunology (Baltimore, Md. : 1950).  1986 September. 137(6):1786-92.
[PubMed]

Carroll T, Schelper R, Goeken J, Kemp J.  Neoplastic angioendotheliomatosis: immunopathologic and morphologic evidence for intravascular malignant lymphomatosis.  American journal of clinical pathology.  1986 February. 85(2):169-75.
[PubMed]

Kemp J, Thorson J, McCalmont T, Kane R, Naumann P.  A monoclonal antibody against the transferrin receptor exhibits highly selective effects on lymphocyte activation.  Fed Proc.  1986. 45.

Shulan D, Wolf S, Weinberger H, Kemp J.  Abs #445 Fluctuating IgG subclass levels in a girl with recurrent sinopulmonary infections.  J Allerg Clin Immunol.  1986. 77:232.

Rohrer J, Kemp J.  Analysis of an SRBC-specific T cell which blocks suppression of MOPC-315 cell secretory differentiation.  Presented at the Sixth International Congress of Immunology, #3.26.18.  1986. 

Argenyi Z, VanRybroek J, Kemp J.  Congenital angiomatoid malignant fibrous histiocytoma. A light microscopic, immunopathologic and electronmicroscopic study.  J Cutan Path.  1986. 13:434.

Kemp J, Rohrer J.  Contrasuppressor T cells (CSTC): Studies in the MOPC-315 system suggest phenotypic and functional heterogeneity.  Presented at the Sixth International Congress of Immunology, #3.27.12.  1986. 

Carroll T, Goeken J, Kemp J.  Neoplastic angioendotheliomatosis: Further evidence for intravascular malignant lymphomatosis.  Lab Invest.  1986. 54:10A.

Koerner T, Weinfeld H, Kemp J.  Abs #3265 H-2 congenic mice exhibit distinct differences in hepatic ganglioside composition.  Fed Proc.  1985. 44:969.

Kemp J, Naumann P, Kane R, Ohshima M, Thorson J.  Abs #3265 Modulation of MOPC-315 surface antigen expression.  Fed Proc.  1985. 44(3):789.

Carroll T, Schelper R, Goeken J, Kemp J.  Neoplastic angioendothelioma tosis (NAE): Immunopathologic evidence for intravascular malignant lymphoma.  Lab Invest.  1985. 52(1):12A.

Ellerbroek R, Foucar K, Kowal-Vern A, Kemp J, Kisker T, Tannous R, Strauss R.  Large cell lymphoma complicating acute lymphoblastic leukemia.  Blood.  1984 April. 63(4):935-9.
[PubMed]

Kemp J, Rohrer J.  Anti-Lyb 2.2 increases proliferation of, and inhibits antibody secretion by, the MOPC-315 plasmacytoma.  Fed Proc.  1984. 43:2892.

Binion S, Ballas Z, Feldbush T, Kemp J, Egen N, Bier M.  Application of recycling isoelectric focusing to recovery of lymphokines from cell culture supernatants.  Electrophoresis; Proceeding of the Electrophoresis Society Meetings.  1984. 45.

Kemp J, Rohrer J.  Heterogeneity of contrasuppressor T cell function and specificity.  Advances in Cancer Research.  1984. 42:326-31.

Kemp J, Rohrer J.  Is MOPC-315 a model for antigen-specific modulation of the Lyb3+, 5+, 7+ B cell subset?.  J Cell Biochem.  1984. 

Rohrer J, Kemp J.  M315-immune secretory differentiation-enhancing TH cells recognize a private idiotope composed of a small hypervariable segment of the lambda2315 light chain and a determinant shared by several lambda2 light chains.  Fed Proc.  1984. 43:2892.

Rohrer J, Janeway Jr C, Kemp J.  Regulation of B cell secretory differentiation and clone growth are mediated by distinct subsets of helper cells which recognize different restriction elements.  J Cell Biochem.  1984. 

Kemp J, Porter J, Huber B.  Anti-Lyb3 antisera reacts with human B lymphocytes.  Advances in Immunology.  1983. 

Kemp J, Rohrer J, Gershon R, Huber B.  Anti-Lyb3 enhances secretory differentiation of B cells: An anti-suppressive mechanism is involved.  Fed Proc.  1983. 42:3820.

Rohrer J, Janeway C, Kemp J.  Anti-Mu treated mice lack certain helper and contrasuppressor T cells.  Advances in Immunology.  1983. 

Rohrer J, Gershon R, Lynch R, Kemp J.  Enhancement of B lymphocyte secretory differentiation by a Ly 1+,2-,Qa-1+ helper T cell subset that sees both antigen and determinants on immunoglobulin.  The Journal of molecular and cellular immunology : JMCI.  1983. 1(1):50-64.
[PubMed]

Rohrer J, Kemp J.  Helper T cell:macrophage:B cell H-2 compatibility requirements are different for activation of clone growth and secretory differentiation in Lyb+ B cells.  Advances in Immunologyf.  1983. 

Rohrer J, Kemp J.  Heterogeneity of contrasuppressor T cell function and specificity.  Fed Proc.  1983. 42:3820.

Hoover R, Dieckgraefe B, Lake J, Kemp J, Lynch R.  Lymphocyte surface membrane immunoglobulin in myeloma. III. IgA plasmacytomas induce large numbers of circulating, adult-thymectomy-sensitive, theta +, Lyt-1-2+ lymphocytes with IgA-Fc receptors.  Journal of immunology (Baltimore, Md. : 1950).  1982 December. 129(6):2329-31.
[PubMed]

Reinisch C, Sing A, Waldron J, Kemp J.  Isolation of malignant and functional Ly 1+ T-cell clones from B-cell lymphomas.  Nature.  1982 July. 298(5870):176-8.
[PubMed]

Rohrer J, Gershon R, Kemp J, Huber B.  Anti-Lyb3 antiserum promotes MOPC-315 secretory differentiation.  J Cell Biochem.  1982. Suppl 6:23.

Rohrer J, Huber B, Gershon R, Kemp J.  Anti-Lyb3 promotes secretory differentiation of the MOPC-315 tumor.  Mid-West Autumn Immunology Conference, C hicago.  1982. 

Roher J, Gershon R, Kemp J.  Distinct populations of SRBC-immune suppressor cells control B cell clone growth and secretory differentiation.  New York: Academic Press.  1982. 

Kemp J, Rohrer J, Huber B.  Lyb3: a B cell surface antigen associated with triggering secretory differentiation.  Immunological reviews.  1982. 69:127-40.
[PubMed]

Kemp J, Madri J.  The immunobiology and immunogenetics of the collagens.  CRC Press.  1982. 

Rohrer J, Gershon R, Lynch R, Kemp J.  Two distinct antigen-induced TH cells promote B cell growth and secretory differentiation.  Fed Proc.  1982. 41:366.

Kemp J, Cowdery J, Steinberg A, Gershon R.  Genetic control of autoimmune disease: interactions between xid and Ipr.  Journal of immunology (Baltimore, Md. : 1950).  1982 January. 128(1):388-92.
[PubMed]

Kemp J, Madri J.  The immune response to human type III and type V (AB2) collagen: antigenic determinants and genetic control in mice.  European journal of immunology.  1981 February. 11(2):90-4.
[PubMed]

Bennett J, Kemp J, Rao V, Mitchell M.  Selectivity in the effects of indomethacin on BCG-activated suppressor cell populations.  Journal of immunopharmacology.  1981. 3(2):221-39.
[PubMed]

Hoover R, Dieckgraefe B, Lake J, Kemp J, Gershon R, Lynch R.  The T-alpha cells induced by IgA secreting plasmacytomas are theta+, Ly1-, 2+, adult-thymectomy sensitive lymphocytes.  Fed P roc.  1981. 40:734.

Rohrer J, Kemp J, Gershon R, Cantor H.  Two T cells interact to effect idiotype-specific suppression of M315 secretion by MOPC-315 cells in vitro.  J Supramol Struct Cell Biochem.  1981. 

Rohrer J, Kemp J, Gershon F, Lynch R, Cantor H.  Two T cells interact to suppress myeloma immunoglobulin secretion.  Fed Proc.  1981. 40:1008.

Kemp J, Dohrman L, Jayawardena A, Huber B, Gershon R.  B-cell subsets in autoimmunity: an autoimmune hemolytic response to mouse erythrocytes is modulated by the CBA/N defect and anti-Lyb3 antisera.  Cellular immunology.  1980 July. 53(1):84-93.
[PubMed]

Eardley D, Murphy D, Kemp J, Shen F, Cantor H, Gershon R.  Ly-1 inducer and Ly-1,2 acceptor T cells in the feedback suppression circuit bear an I-J-subregion controlled determinant.  Immunogenetics.  1980. 11(6):549-57.
[PubMed]

Kemp J.  Sex-linked recessive modulation of a lymphoproliferative/autoimmune phenotype.  Fed Proc.  1980. 39:1596.

Kemp J, Louie D, Mattingly J, Bennett J, Higuchi C, Pretell J, Horowitz M, Gershon R.  Suppressor cells in vitro: differential effects of indomethacin and related compounds.  Journal of immunopharmacology.  1980. 2(4):471-89.
[PubMed]

Jayawardena A, Janeway C, Kemp J.  Experimental malaria in the CBA/N mouse.  Journal of immunology (Baltimore, Md. : 1950).  1979 December. 123(6):2532-9.
[PubMed]

Mattingly J, Kemp J.  Suppression of secondary plaque-forming cell responses by rat splenic adherent cells: evidence for dependence on prostaglandin production.  Cellular immunology.  1979 November. 48(1):195-200.
[PubMed]

Eardley D, Kemp J, Shen F, Cantor H, Gershon R.  Immunoregulatory circuits among T cell sets: effect of mode of immunization on determining which Lyl T cell sets will be activated.  Journal of immunology (Baltimore, Md. : 1950).  1979 May. 122(5):1663-5.
[PubMed]

Jayawardena A, Kemp J.  Immunity to Plasmodium yoelii and Babesia microti: modulation by the CBA/N X-chromosome.  Bulletin of the World Health Organization.  1979. 57 Suppl 1:255-9.
[PubMed]

Mattingly J, Eardley D, Kemp J, Gershon R.  Induction of suppressor cells in rat spleen: Influence of microbial stimulation.  Journal of Immunology.  1979. 122:787-90.

Cantor H, Hugenberger J, McVay-Boudreau L, Eardley D, Kemp J, Shen F, Gershon R.  Immunoregulatory circuits among T-cell sets - Identification of a subpopulation of T-helper cells that induces feedback inhibition.  The Journal of experimental medicine.  1978 October. 148(4):871-7.
[PubMed]

Kemp J, Stenn K, Arons M, Fischer J.  Metastasizing atypical fibroxanthoma - Coexistence with chronic lymphocytic leukemia.  Archives of dermatology.  1978 October. 114(10):1533-5.
[PubMed]

Janeway C, Murphy P, Kemp J, Wigzell H.  T cells specific for hapten-modified self are precommitted for self major histocompatibility complex antigens before encounter with the hapten.  The Journal of experimental medicine.  1978 April. 147(4):1065-77.
[PubMed]

Gershon R, Horowitz M, Kemp J, Murphy D, Murphy E.  The cellular site of immunoregulatory breakdown in the lpr mutant mouse.  (North Holland) Elsevier.  1978. 1:223-226.

Date Last Modified: 06/07/2014 - 21:56:23